CNS Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNSP and other ETFs, options, and stocks.About CNSP
CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12.
CEORami Levin
CEORami Levin
Employees5
Employees5
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded2017
Founded2017
Employees5
Employees5
CNSP Key Statistics
Market cap3.94M
Market cap3.94M
Price-Earnings ratio-0.11
Price-Earnings ratio-0.11
Dividend yield—
Dividend yield—
Average volume12.09K
Average volume12.09K
High today$6.52
High today$6.52
Low today$6.00
Low today$6.00
Open price$6.12
Open price$6.12
Volume9.27K
Volume9.27K
52 Week high$114.00
52 Week high$114.00
52 Week low$4.93
52 Week low$4.93
Stock Snapshot
As of today, CNS Pharmaceuticals(CNSP) shares are valued at $6.44. The company's market cap stands at 3.94M, with a P/E ratio of -0.11.
As of 2026-01-14, CNS Pharmaceuticals(CNSP) stock has fluctuated between $6.00 and $6.52. The current price stands at $6.44, placing the stock +7.3% above today's low and -1.2% off the high.
The CNS Pharmaceuticals(CNSP)'s current trading volume is 9.27K, compared to an average daily volume of 12.09K.
In the last year, CNS Pharmaceuticals(CNSP) shares hit a 52-week high of $114.00 and a 52-week low of $4.93.
In the last year, CNS Pharmaceuticals(CNSP) shares hit a 52-week high of $114.00 and a 52-week low of $4.93.
People also own
Based on the portfolios of people who own CNSP. This list is generated using Robinhood data, and it’s not a recommendation.